Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Related Citations for PubMed (Select 10770911)

1.

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.

Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, Holmberg S, Jones JL.

Clin Infect Dis. 2000 Apr;30 Suppl 1:S5-14. Review.

2.

Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.

Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, Ward J.

MMWR CDC Surveill Summ. 1999 Apr 16;48(2):1-22.

PMID:
12412613
3.

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Ylitalo N, Brogly S, Hughes MD, Nachman S, Dankner W, Van Dyke R, Seage GR 3rd; Pediatric AIDS Clincial Trials Group Protocol 219C Team.

Arch Pediatr Adolesc Med. 2006 Aug;160(8):778-87.

PMID:
16894075
4.

Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.

Dankner WM, Lindsey JC, Levin MJ; Pediatric AIDS Clinical Trials Group Protocol Teams 051, 128, 138, 144, 152, 179, 190, 220, 240, 245, 254, 300 and 327.

Pediatr Infect Dis J. 2001 Jan;20(1):40-8.

PMID:
11176565
5.

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.

Weverling GJ, Mocroft A, Ledergerber B, Kirk O, Gonzáles-Lahoz J, d'Arminio Monforte A, Proenca R, Phillips AN, Lundgren JD, Reiss P.

Lancet. 1999 Apr 17;353(9161):1293-8.

PMID:
10218526
6.

Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.

Podlasin RB, Wiercinska-Drapalo A, Olczak A, Beniowski M, Smiatacz T, Malolepsza E, Juszczyk J, Leszczyszyn-Pynka M, Mach T, Mian M, Knysz B, Horban A.

Infection. 2006 Aug;34(4):196-200.

PMID:
16896577
7.

[Approach to opportunistic illness in the HAART era].

Imamura A.

Nihon Rinsho. 2002 Apr;60(4):757-62. Review. Japanese.

PMID:
11968784
8.

[Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].

Pozio E.

Parassitologia. 2004 Jun;46(1-2):89-93. Review. Italian.

PMID:
15305694
9.
10.

Pneumocystis carinii pneumonia.

Schliep TC, Yarrish RL.

Semin Respir Infect. 1999 Dec;14(4):333-43. Review.

PMID:
10638513
11.

Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy.

Soriano V, Dona C, Rodríguez-Rosado R, Barreiro P, González-Lahoz J.

AIDS. 2000 Mar 10;14(4):383-6.

PMID:
10770540
12.

High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States.

Gebo KA, Fleishman JA, Reilly ED, Moore RD; HIV Research Network.

Med Care. 2005 Sep;43(9 Suppl):III23-30.

PMID:
16116306
13.
14.

Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxis.

Abgrall S, Matheron S, Le Moing V, Dupont C, Costagliola D; Clinical Epidemiology Group from the French Hospital Database on HIV.

J Acquir Immune Defic Syndr. 2001 Feb 1;26(2):151-8.

PMID:
11242182
15.

The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.

Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, Rathore M, Read JS, Huang S, Elgie C, Hudgens K, Hughes W.

Pediatrics. 2005 Apr;115(4):e488-94. Epub 2005 Mar 16.

PMID:
15772172
17.

Opportunistic infections update.

[No authors listed]

Proj Inf Perspect. 1999 Apr;(27):19-20.

PMID:
11366735
18.

Opportunistic infections: an update.

Furrer H, Fux C.

J HIV Ther. 2002 Feb;7(1):2-7. Review.

PMID:
11956497
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk